These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 26398012)

  • 1. Systemic sclerosis-associated fibrosis: an accelerated aging phenotype?
    Luckhardt TR; Thannickal VJ
    Curr Opin Rheumatol; 2015 Nov; 27(6):571-6. PubMed ID: 26398012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early inflammatory players in cutanous fibrosis.
    Raker V; Haub J; Stojanovic A; Cerwenka A; Schuppan D; Steinbrink K
    J Dermatol Sci; 2017 Sep; 87(3):228-235. PubMed ID: 28655471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic factors as drivers of fibrosis in systemic sclerosis.
    Bergmann C; Distler JH
    Epigenomics; 2017 Apr; 9(4):463-477. PubMed ID: 28343418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Basis of Accelerated Aging with Immune Dysfunction-Mediated Inflammation (Inflamm-Aging) in Patients with Systemic Sclerosis.
    Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
    Cells; 2021 Dec; 10(12):. PubMed ID: 34943909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular senescence and autophagy in the pathogenesis of chronic obstructive pulmonary disease (COPD) and idiopathic pulmonary fibrosis (IPF).
    Kuwano K; Araya J; Hara H; Minagawa S; Takasaka N; Ito S; Kobayashi K; Nakayama K
    Respir Investig; 2016 Nov; 54(6):397-406. PubMed ID: 27886850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondria, Aging, and Cellular Senescence: Implications for Scleroderma.
    Bueno M; Papazoglou A; Valenzi E; Rojas M; Lafyatis R; Mora AL
    Curr Rheumatol Rep; 2020 Jun; 22(8):37. PubMed ID: 32562128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving insights into the cellular and molecular pathogenesis of fibrosis in systemic sclerosis.
    Korman B
    Transl Res; 2019 Jul; 209():77-89. PubMed ID: 30876809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts.
    Wang Y; Fan PS; Kahaleh B
    Arthritis Rheum; 2006 Jul; 54(7):2271-9. PubMed ID: 16802366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic mechanisms: An emerging role in pathogenesis and its therapeutic potential in systemic sclerosis.
    Luo Y; Wang Y; Shu Y; Lu Q; Xiao R
    Int J Biochem Cell Biol; 2015 Oct; 67():92-100. PubMed ID: 26043891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic factors in systemic sclerosis.
    Mayes MD; Trojanowska M
    Arthritis Res Ther; 2007; 9 Suppl 2(Suppl 2):S5. PubMed ID: 17767743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic sclerosis: a prototypic multisystem fibrotic disorder.
    Varga J; Abraham D
    J Clin Invest; 2007 Mar; 117(3):557-67. PubMed ID: 17332883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.
    Altorok N; Almeshal N; Wang Y; Kahaleh B
    Rheumatology (Oxford); 2015 Oct; 54(10):1759-70. PubMed ID: 24740406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered MCM protein levels and autophagic flux in aged and systemic sclerosis dermal fibroblasts.
    Dumit VI; Küttner V; Käppler J; Piera-Velazquez S; Jimenez SA; Bruckner-Tuderman L; Uitto J; Dengjel J
    J Invest Dermatol; 2014 Sep; 134(9):2321-2330. PubMed ID: 24496236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel insights on the role of the innate immune system in systemic sclerosis.
    York MR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):481-9. PubMed ID: 21790291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A Uuifying hypothesis for the pathogenesis of systemic sclerosis based on the deficiency of transcription factor Fli1 - the development of a new animal model of systemic sclerosis -].
    Asano Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2014; 37(6):475-87. PubMed ID: 25748132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fibroblast abnormalities in the pathogenesis of systemic sclerosis.
    Usategui A; del Rey MJ; Pablos JL
    Expert Rev Clin Immunol; 2011 Jul; 7(4):491-8. PubMed ID: 21790292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells in systemic sclerosis: a reappraisal.
    O'Reilly S; Hügle T; van Laar JM
    Rheumatology (Oxford); 2012 Sep; 51(9):1540-9. PubMed ID: 22577083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigenetic suppression of Fli1, a potential predisposing factor in the pathogenesis of systemic sclerosis.
    Asano Y
    Int J Biochem Cell Biol; 2015 Oct; 67():86-91. PubMed ID: 26055516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Innovative antifibrotic therapies in systemic sclerosis.
    Beyer C; Distler O; Distler JH
    Curr Opin Rheumatol; 2012 May; 24(3):274-80. PubMed ID: 22450392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of cellular senescence in the pathogenesis of systemic sclerosis.
    Tsou PS; Shi B; Varga J
    Curr Opin Rheumatol; 2022 Nov; 34(6):343-350. PubMed ID: 35979691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.